B.J. Rimel named medical director of Cedars-Sinai’s Cancer Clinical Trials Office

Ze’ev Ronai receives NCI Outstanding Investigator Award

Ze’ev Ronai, a cancer investigator and director of the Translational Research Institute at Cedars-Sinai, received an Outstanding Investigator Award from NCI.

February 21, 2025

Vol.51 No.07

Clinical Roundup

First FDA-approved robot-assisted microsurgery for head-and-neck cancer performed at Cedars-Sinai

Cedars-Sinai performed the first robot-assisted microsurgical head-and-neck cancer reconstructive surgery in the United States after the robot device received FDA approval for the procedure.

February 21, 2025

Vol.51 No.07

Clinical Roundup

Cortechs.ai, EDAP TMS announce OnQ prostate-assisted robotic HIFU procedure

Cortechs.ai and EDAP TMS SA announced the successful completion of the world’s first OnQ Prostate-assisted Focal One Robotic HIFU procedure at the University of California, San Francisco Prostate Center.

February 14, 2025

Vol.51 No.06

Clinical Trials & Tribulations

Physicians and biopharma should improve accessibility of cancer trials

Oncological clinical trials pave the way for better patient outcomes and accelerate critical cancer treatments. Their legacy structure, however, often stands in their own way.

Thyroid cancer continues to be overdiagnosed, Cedars-Sinai study finds

A study led by Cedars-Sinai investigators provides evidence that thyroid cancer continues to be overdiagnosed and that aggressive screening and treatment of thyroid cancer has not led to higher survival rates.

February 07, 2025

Vol.51 No.05

Clinical Roundup

Dual-targeted therapies + chemo shows high response rates in BRAF-mutated metastatic CRC, phase III trial shows

Patients with metastatic colorectal cancer harboring BRAF V600E mutations benefitted from first-line treatment with the targeted therapies Braftovi(encorafenib) and Erbitux(cetuximab) plus a mFOLFOX6 chemotherapy regimen, according to results from the phase III BREAKWATER trial led by researchers at the University of Texas MD Anderson Cancer Center.

January 31, 2025

Vol.51 No.04

B.J. Rimel named medical director of Cedars-Sinai’s Cancer Clinical Trials Office

YOU MAY BE INTERESTED IN

Ze’ev Ronai receives NCI Outstanding Investigator Award

First FDA-approved robot-assisted microsurgery for head-and-neck cancer performed at Cedars-Sinai

Cortechs.ai, EDAP TMS announce OnQ prostate-assisted robotic HIFU procedure

Physicians and biopharma should improve accessibility of cancer trials

Thyroid cancer continues to be overdiagnosed, Cedars-Sinai study finds

Dual-targeted therapies + chemo shows high response rates in BRAF-mutated metastatic CRC, phase III trial shows

Renew today!

Subscriber content

Never miss an issue!

Login